Drugs / Diacerin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02470689 Comparator | Jun 2015 → Dec 2017 | epidermolysis bullosa simplex | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diacerin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02470689 ↗ |
| Known as | diacerein | “the small molecule diacerein” NCT02470689 ↗ |
| Modality | Small molecule | “the small molecule diacerein” NCT02470689 ↗ |